Published in PLoS One on March 06, 2012
Forkhead box proteins: tuning forks for transcriptional harmony. Nat Rev Cancer (2013) 2.02
Nutrient-sensing pathways and metabolic regulation in stem cells. J Cell Biol (2013) 1.08
The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness. Cell Cycle (2013) 0.99
FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop. PLoS One (2012) 0.95
DAF-16/FoxO directly regulates an atypical AMP-activated protein kinase gamma isoform to mediate the effects of insulin/IGF-1 signaling on aging in Caenorhabditis elegans. PLoS Genet (2014) 0.84
Transcription factor NF-Y is a functional regulator of the transcription of core clock gene Bmal1. J Biol Chem (2013) 0.79
Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action. PLoS Comput Biol (2015) 0.79
Identification and Functional Characterization of Novel Genetic Variations in the OCTN1 Promoter. Korean J Physiol Pharmacol (2014) 0.78
Histone deacetylase inhibition protects hearing against acute ototoxicity by activating the Nf-κB pathway. Cell Death Discov (2015) 0.78
Transcription factor NF‑YA promotes a malignant phenotype by upregulating fatty acid synthase expression. Mol Med Rep (2016) 0.75
Establishment of an Immortalized Skin Keratinocyte Cell Line Derived from the Animal Model Mastomys coucha. PLoS One (2016) 0.75
Community Structure Reveals Biologically Functional Modules in MEF2C Transcriptional Regulatory Network. Front Physiol (2016) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell (1999) 32.32
Promoter sequences of eukaryotic protein-coding genes. Science (1980) 19.96
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol (2003) 12.91
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A (2004) 12.30
Unlocking the secrets of the genome. Nature (2009) 11.80
Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev Cancer (2008) 11.50
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35
Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays. Nat Methods (2006) 8.52
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer (2009) 8.43
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature (2000) 8.35
LKB1 modulates lung cancer differentiation and metastasis. Nature (2007) 7.80
The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell (2004) 7.77
Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature (1999) 7.66
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet (1998) 7.36
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res (2002) 7.09
The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol (2010) 6.91
A multiplicity of CCAAT box-binding proteins. Cell (1987) 6.37
LKB1-dependent signaling pathways. Annu Rev Biochem (2006) 5.91
Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol Cell Biol (2001) 5.78
Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med (1949) 5.35
Identification of the differential distribution patterns of mRNAs and consensus binding sequences for mouse DAF-16 homologues. Biochem J (2000) 5.30
The Sp-family of transcription factors. Gene (1999) 5.05
Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol (2007) 4.73
The molecular biology of the CCAAT-binding factor NF-Y. Gene (1999) 4.36
The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem (2007) 4.22
FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP. Nat Cell Biol (2006) 4.14
Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending. EMBO J (1994) 3.20
Target Detection Assay (TDA): a versatile procedure to determine DNA binding sites as demonstrated on SP1 protein. Nucleic Acids Res (1990) 3.08
AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge. Biochem J (1999) 2.75
Forkhead transcription factors contribute to execution of the mitotic programme in mammals. Nature (2001) 2.43
Somatic LKB1 mutations promote cervical cancer progression. PLoS One (2009) 2.21
Human cell hybrids: analysis of transformation and tumorigenicity. Science (1982) 2.16
High proportion of large genomic STK11 deletions in Peutz-Jeghers syndrome. Hum Mutat (2005) 2.09
Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci U S A (1999) 2.04
Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene (2000) 1.83
Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res (2002) 1.60
LKB1 exonic and whole gene deletions are a common cause of Peutz-Jeghers syndrome. J Med Genet (2006) 1.56
NF-Y is essential for the recruitment of RNA polymerase II and inducible transcription of several CCAAT box-containing genes. Mol Cell Biol (2005) 1.52
Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res (2007) 1.42
SIK1 couples LKB1 to p53-dependent anoikis and suppresses metastasis. Sci Signal (2009) 1.35
Major histocompatibility complex class II-associated invariant chain gene expression is up-regulated by cooperative interactions of Sp1 and NF-Y. J Biol Chem (1995) 1.13
Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter. J Biol Chem (1996) 1.10
Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose. J Biol Chem (2003) 1.03
Glucocorticoid receptor activation signals through forkhead transcription factor 3a in breast cancer cells. Mol Endocrinol (2006) 1.02
FHX, a novel fork head factor with a dual DNA binding specificity. J Biol Chem (2000) 0.96
Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells. J Biol Chem (2004) 0.94
Systematic identification of cis-silenced genes by trans complementation. Hum Mol Genet (2008) 0.88
Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1. Biochem J (2007) 0.87
Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region. J Biol Chem (2007) 0.84
The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Lett (2002) 1.20
Epigenetic silencing of interferon-kappa in human papillomavirus type 16-positive cells. Cancer Res (2009) 1.07
Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell Oncol (2008) 1.01
Post-translational control of IL-1β via the human papillomavirus type 16 E6 oncoprotein: a novel mechanism of innate immune escape mediated by the E3-ubiquitin ligase E6-AP and p53. PLoS Pathog (2013) 1.00
PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro. Mol Cancer (2011) 0.98
Nucleolin as activator of human papillomavirus type 18 oncogene transcription in cervical cancer. J Exp Med (2002) 0.98
Cutaneous HPV23 E6 prevents p53 phosphorylation through interaction with HIPK2. PLoS One (2011) 0.97
Alternative splicing of human papillomavirus type-16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci U S A (2010) 0.96
Regulation of MCP-1 chemokine transcription by p53. Mol Cancer (2010) 0.96
FOXO3 is a glucocorticoid receptor target and regulates LKB1 and its own expression based on cellular AMP levels via a positive autoregulatory loop. PLoS One (2012) 0.95
Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. Int J Cancer (2003) 0.95
Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells. J Biol Chem (2004) 0.94
Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection. J Gen Virol (2007) 0.93
HDAC inhibitors trigger apoptosis in HPV-positive cells by inducing the E2F-p73 pathway. Oncogene (2004) 0.93
Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene (2002) 0.92
HPV vaccination for prevention of skin cancer. Hum Vaccin Immunother (2015) 0.88
Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1. Biochem J (2007) 0.87
A novel rodent papillomavirus isolated from anogenital lesions in its natural host. Virology (2008) 0.87
Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells. J Virol (2002) 0.87
Histone deacetylase inhibitor-induced sensitization to TNFalpha/TRAIL-mediated apoptosis in cervical carcinoma cells is dependent on HPV oncogene expression. Int J Cancer (2010) 0.86
Growth arrest of HPV-positive cells after histone deacetylase inhibition is independent of E6/E7 oncogene expression. Virology (2002) 0.86
Retinoic acid receptor beta silences human papillomavirus-18 oncogene expression by induction of de novo methylation and heterochromatinization of the viral control region. J Biol Chem (2007) 0.84
The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Mol Carcinog (2002) 0.82
Increased incidence of squamous cell carcinomas in Mastomys natalensis papillomavirus E6 transgenic mice during two-stage skin carcinogenesis. J Virol (2004) 0.82
Sulindac induces specific degradation of the HPV oncoprotein E7 and causes growth arrest and apoptosis in cervical carcinoma cells. Cancer Lett (2006) 0.81
Serological markers for papillomavirus infection and skin tumour development in the rodent model Mastomys coucha. J Gen Virol (2010) 0.81
Silencing of multi-copy HPV16 by viral self-methylation and chromatin occlusion: a model for epigenetic virus-host interaction. Hum Mol Genet (2011) 0.79
The functional role of Notch signaling in HPV-mediated transformation is dose-dependent and linked to AP-1 alterations. Cell Oncol (Dordr) (2012) 0.79
Involvement of net and Hif1alpha in distinct yet intricately linked hypoxia-induced signaling pathways. J Biol Chem (2010) 0.79
Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cells. J Biol Chem (2004) 0.78
Molecular pathogenesis of squamous cell carcinoma. Cancer Treat Res (2009) 0.78
A capture ELISA for monitoring papillomavirus-induced antibodies in Mastomys coucha. J Virol Methods (2009) 0.76
Tyrphostin AG 555 inhibits bovine papillomavirus transcription by changing the ratio between E2 transactivator/repressor function. J Biol Chem (2003) 0.75
Male urethral Pap smears and peniscopy examination and polymerase chain reaction human papillomavirus correlation. Diagn Cytopathol (2011) 0.75
Genetic redundancy in human cervical carcinoma cells: identification of cells with "normal" properties. Int J Cancer (2007) 0.75